Berggren A, Sillén U, Rubenson A
Department of Pediatric Surgery, Ostra sjukhuset, Göteborg, Sweden.
Acta Physiol Scand. 1992 May;145(1):33-7. doi: 10.1111/j.1748-1716.1992.tb09333.x.
Bladder motility recordings were performed in anaesthetized rats and the effect of the peripherally active opiate agonist loperamide on urinary bladder function was studied. Regional intra-arterial administration of loperamide (0.01-2 mg kg-1) induced weak bladder contraction per se. Loperamide caused an effective dose-dependent inhibition of bladder motility induced by regional injection of the receptor agonists acetylcholine (ACh) and substance P (SP), as well as by peripheral motor nerve stimulation (PNS). Pretreatment with naloxone (0.5 mg kg-1) partially antagonized the inhibitory action of loperamide on the nerve-mediated detrusor contraction. However, the depression of the motor responses induced by the receptor agonists ACh and SP was not influenced. It is suggested that the demonstrated inhibitory effect of loperamide on bladder motility is partially mediated by peripheral opioid receptors. The main non-opioid part of the inhibition might be a direct smooth muscle action.
在麻醉大鼠身上进行膀胱动力记录,并研究外周活性阿片类激动剂洛哌丁胺对膀胱功能的影响。局部动脉注射洛哌丁胺(0.01 - 2毫克/千克)本身可引起轻微的膀胱收缩。洛哌丁胺对局部注射受体激动剂乙酰胆碱(ACh)和P物质(SP)以及外周运动神经刺激(PNS)诱导的膀胱动力产生有效剂量依赖性抑制。用纳洛酮(0.5毫克/千克)预处理可部分拮抗洛哌丁胺对神经介导的逼尿肌收缩的抑制作用。然而,受体激动剂ACh和SP诱导的运动反应的抑制不受影响。提示洛哌丁胺对膀胱动力的抑制作用部分由外周阿片受体介导。抑制作用的主要非阿片类部分可能是直接的平滑肌作用。